Skip to main content
main-content

01.03.2012 | Case report | Ausgabe 1/2012

International Cancer Conference Journal 1/2012

Metastatic prostate carcinoma detected at lymph node dissection for thyroid papillary carcinoma: report of a case

Zeitschrift:
International Cancer Conference Journal > Ausgabe 1/2012
Autoren:
Takayuki Yamamoto, Yoshihiro Tominaga, Toyonori Tsuzuki, Takahisa Hiramitsu, Koji Nanmoku
Wichtige Hinweise
This case was presented at the 23rd Annual Congress of the Japan Association of Endocrine Surgeons (7 July 2011, Tokyo).

Abstract

Skip metastasis from prostate cancer to cervical lymph nodes is very uncommon. We report the case of a 74-year-old man who was admitted to our hospital because of a thyroid cancer. Preoperative computed tomography (CT) imaging of the head and neck verified the previously detected mass at the left lobe of the thyroid gland. Cervical lymph nodes or signs of lung metastasis could not be found. The patient subsequently underwent total thyroidectomy with dissection of the central (I, II, III) and lateral zone lymph nodes (IV, Va, VI, VII). The diagnosis became T2Ex0N0M0. Histology verified a differentiated papillary thyroid carcinoma. Immunohistological examination showed that the origin of the metastases in the left cervical lymph nodes was the prostate and not the papillary thyroid carcinoma (PSA, PAP, p501S, p504S positive, CK7, CK20, p63, thyroglobulin-negative). The patient was referred to a urologist and prostate carcinoma was diagnosed by biopsy. The PSA level was 56.87 ng/ml and transrectal ultrasonography showed a prostate mass of 46 × 40 × 55 mm in size. Hormonal therapy decreased the PSA level to 3.74 ng/ml at 6 months after the operation. His general health condition is now good. This is the first report, as far as we know, describing a man whose prostate cancer was detected in the cervical lymph nodes after undergoing surgery for thyroid cancer.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2012

International Cancer Conference Journal 1/2012 Zur Ausgabe
  1. Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise